drugset / Trial / NCT00990795

Trial of Cyclosporine for Myocardial Protection During Open Heart Surgery

NCT00990795

RandomizedFactorialQuadruple-blindTreatment

Summary

Administration of cyclosporine has been found to have a myocardial protective effect, improving post-operative cardiac function in patients undergoing percutaneous coronary interventions by diminishing infarct size. The purpose of the proposed study is to conduct a randomized, controlled clinical trial in patients undergoing isolated valvular heart surgery, or coronary artery bypass surgery. Specifically the investigators will evaluate the cardio-protective effects of cyclosporine on post ischemic-arrest myocardium. The two factors will be treatment group and cyclosporine versus placebo.

Timeline

Start
2010-04
Primary completion
2010-10
Completion
2010-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclosporine Peptide 2.5 mg/kg Intravenous